Abstract:Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Research has shown that lysosome-mediated autophagy is up regulated in response to various stimuli such as hypoxia, nutrient limitation, and drug-induced cytotoxic stress. In cancer progression, autophagy plays a cytoprotective role by generating needed nutrients or by eliminating damaged cellular components. Although autophagy has been recognized as a critical tumor cell survival mechanism and much is known about the induction and early steps of autophagy, the molecule(s) which control the later stages of autophagic progression are less clear. Previously, we have identified lysosomal-associated protein transmembrane 4b (LAPTM4B) as an amplified and over-expressed gene in breast cancer that is associated with de novo resistance to anthracycline chemotherapy and increased risk of distant metastatic recurrence. We reported that LAPTM4B overexpression alters intracellular trafficking of anthracyclines by retaining the drug in the cytoplasmic compartment thereby limiting drug-induced DNA damage in the nucleus. However, how this protein contributes to tumor cell survival in the setting of other types of stress requires further investigation. In the present studies, we used fluorescence microscopy to confirm LAPTM4B protein distribution in the lysosomal compartment of cells. Depletion of this gene results in increased lysosome membrane permeability as demonstrated by release from lysosomes of low to intermediate molecular weight dextran. Furthermore, we find that over expression of LAPTM4B renders cells resistant to apoptosis when placed in nutrient-free media suggesting a possible role of LAPTM4B in promoting lysosome-mediated autophagy. We induced autophagy by serum starvation in BT549 breast cancer cells with or without depletion of LAPTM4B. Autophagic progression was monitored by immunofluorescence for the autophagosome marker, LC3, and for degradation of P62 as evidence of autolysosome maturation. We find that depletion of LAPTM4B interrupted autophagosome maturation to autolysosomes as indicated by appearance of LC3 but absence of P62 degradation. In addition, we observed aggregation of autophagosomes in LAPTM4B-depleted cells and caspase activation, indicative of apoptosis. These events are a recognized sequela of blocked autophagic maturation. In summary, we find that ablation of LAPTM4B results in increased lysosome membrane permeability, inhibition of autophagosome-lysosome fusion, and toxic accumulation of autophagasomes triggering cell death. These results suggest a novel function for the amplified cancer gene, LAPTM4B, in promoting the later stages of autophagic maturation and tumor resistance to apoptosis-inducing stress. Targeting LAPTM4B may provide a new strategy to prevent metabolic adaptation of cancer cells by abolishing the cytoprotective effects of autophagy and increasing drug therapy efficacy. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 3772. doi:10.1158/1538-7445.AM2011-3772

P2-04-02: Identification of a Novel Glycosyltransferase-Like Gene As an Autophagic Inducer in Human Mammary Carcinoma Cells Via Down Regulation of BCL-2.

Downregulation of GLYAT facilities tumor growth and metastasis and poor clinical outcomes through the PI3K/AKT/Snail pathway in human breast cancer

Overexpression of Glucose-Regulated Protein 78 in Colon Cancer.

Identification of Carboxypeptidase of Glutamate Like-B As a Candidate Suppressor in Cell Growth and Metastasis in Human Hepatocellular Carcinoma.

Identification And Characterization Of Survival-Related Gene, A Novel Cell Survival Gene Controlling Apoptosis And Tumorigenesis

Abstract 2260: Novel Molecular Therapy Targeting Mcl-1 and Modulating Autophagy in Castration-Resistant Prostate Cancer

Abstract 4378: Identification of novel TXNIP-dependent antitumor pathways in breast cancer

Abstract B53: The role of RPL39 induced autophagy in resistance of breast cancer stem cells

Overexpression of A Novel Tumor Metastasis Suppressor Gene Tmsg1/Lass2 Induces Apoptosis Via A Caspase-Dependent Mitochondrial Pathway

Abstract LB444: Identification of a novel and selective Transglutaminase 2 (TGM2) inhibitors modulate tumor microenvironment in Glioblastoma

The Amplified Cancer Gene Laptm4b Plays A Critical Role In Autophagosome Maturation And Promotes Cancer Cell Survival During Metabolic Stress

P11.52 Reduced Expression of Proteolipid Protein 2 Increases ER-stress-induced Apoptosis and Autophagy in Glioblastoma

The Bcl-2 Homology Domain 3 Mimetic Gossypol Induces Both Beclin 1-Dependent And Beclin 1-Independent Cytoprotective Autophagy In Cancer Cells

The Novel Bh-3 Mimetic Apogossypolone Induces Beclin-1-And Ros-Mediated Autophagy in Human Hepatocellular Cells

B3GALT4 modulates tumor progression and autophagy by AKT/mTOR signaling pathway in breast cancer

Autophagy and lysosomal related protein expression patterns in human glioblastoma

Identification of Novel Caspase/Autophagy-Related Gene Switch to Cell Fate Decisions in Breast Cancers

Abstract 4884: Involvement of autophagy in penta-1,2,3,4,6-O-galloyl-beta-D-glucose-induced senescence-like growth arrest in human cancer cells.

TP53INP2-related Basal Autophagy is Involved in the Growth and Malignant Progression in Human Liposarcoma Cells.

Abstract 2957: Inhibition of Glutaminase Induces Slows Tumor Growth Cell Autonomously and Promotes Survival in a MYC Driven Hepatocellular Carcinoma Mouse Model

Gene Expression Profiling to Identify Oncogenic Determinants of Autocrine Human Growth Hormone in Human Mammary Carcinoma.